In summary, the findings presented here increase our understanding of the cellular mechanisms increasing SERT function that may identify potential therapeutic approaches to manage GI disorders where SERT is dysregulated (such as infectious diarrhea and IBD). Here, SLC6A4 is linked to irritable bowel syndrome.